ETTLINGEN, Germany--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRisk PACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ ...
Bruker Corporation BRKR recently launched PhenoRisk PACS RuO— a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples. The novel NMR test leverages a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results